REGENXBIO clinical trials we track

Check company identity source

Phase 3 1 trial

TrialDrugs studiedStatusPrimary completion
RGX-121-3102 Gene Therapy in Participants With MPS II (Hunter Syndrome)NCT07236606RGX-121-3102Active not recruiting2028-04-30Estimated

Phase 2 / 3 2 trials

TrialDrugs studiedStatusPrimary completion
AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD)NCT05693142RGX-202Active not recruiting2026-09Estimated
CAMPSIITE™ RGX-121 Gene Therapy in Subjects With MPS II (Hunter Syndrome)NCT03566043RGX-121Active not recruiting2023-11-27Actual

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters